Press release
Polypeptide Market Prediction Report 2018: Chemotherapeutic Medicines and Anti-Cancer Pharmaceuticals will Drive the Global Market
Fact.MR
Request TOC of this Report@ https://www.factmr.com/connectus/sample?flag=T&rep_id=796
Applications in Chemotherapeutic Medicines and Anti-Cancer Pharmaceuticals to Boost the Polypeptide Market
With an increasing number of patients diagnosed with cancer, many pharmaceutical companies are conducting intensive research to discover effective anti-cancer drugs. The World Health Organization (WHO), cancer was the second leading cause of death, killing over 8.8 million people across the globe. 70% patients in low- or middle-income countries, who are diagnosed with cancer succumb to death. It generates needs for an effective oncology medicine that can reduce the number of deaths caused by cancer. Due to their chemical structure, polypeptides are used widely in treatments for cancer, especially hormone-dependent cancers, which is the main factor driving the growth of the polypeptide market.
The National Cancer Institute estimates that more than 1.73 million new cases of cancer will be diagnosed in 2018. It also predicts that around cancer will cause over 609,640 deaths in the U.S. by the end of 2018. Owing to the limitation of conventional chemotherapeutic medicines, a growing number of pharmaceutical companies are using polypeptides to manufacture medicines used in cancer therapies. Improved effectiveness of oncology medicines manufactured using polypeptides is triggering the growth of the polypeptide market. It is expected that the number of cancer survivors may increase from 15.5 million in 2016 to over 20.3 million in 2026. It is expected to boost demand for polypeptides in the pharmaceutical industry and contribute to the growth of the polypeptide market. For an instance, by making the use of right polypeptide to make anti-cancer drugs, Nano Intelligence Biomedical Engineering Corporation (NIBEC) recently acquired an anti-cancer peptide patent, named “Anti-Cancer Peptide for Inhibition of Proliferation on the Cancer Stem Cells and Use Thereof,”, in the U.S.
Advancements in Technology to Widen the Range of Industrial Applications of Polypeptides
Depending upon the length of clinical evaluation and new potential leads in genomics, the demand for polypeptides is expected to remain high in biotechnological and pharmaceutical applications. Its growing applications in the biomedical industry are complementing the expansion of the polypeptide market. The growth of the polypeptide is mainly attributed to the enormous interest of pharmaceutical manufacturers in antimicrobial peptides (AMPs), which play an important therapeutic role in wound healing or regeneration. When used in vaccines, polypeptides provide complete protection against various infectious diseases. Manufacturers in the polypeptides market are leveraging the chemical diversity and amino acid sequences of polypeptides to control biological cellular functions and provide more effective biomedical solutions.
Pre-Book Polypeptide Market Research Report@ https://www.factmr.com/checkout/782/S
Apart from the pharmaceutical industry, the cosmetics and personal care industry is likely to influence the growth of the polypeptide market in the upcoming years. Owing to the benefits of polypeptides in nourishing collagen in the human skin, polypeptide remains the most sought-after ingredient among various skincare and cosmetic manufacturers. Elemis, a luxury skincare brand, recently introduced a skincare product that, the company affirms, is ‘the next generation of anti-aging skincare’. The company used Drone Peptide Technology, which acts as a targeted delivery system to improve the skin hydration and anti-aging processes.
Technological Innovations: An Emerging Trend in the Polypeptide Market
The future prospects of the polypeptide market are influenced by the emergence of advanced technologies, and it is expected to improve its applications range in the upcoming years. Manufacturers in the polypeptides market are benefiting from technological advancements to improve the quality of their products. Nuritas, Ltd. – a leading biotechnology firm in the polypeptide market – announced that it will be using artificial intelligence algorithms along with deep learning and genomics to predict the effects of various food-derived bioactive peptides before using them. BASF SE, a German chemical company, has collaborated with Nuritas to incorporate advanced technologies like Artificial Intelligence to discover novel food and health ingredients. Nuritas also stated that it has already raised over US$ 20 million to discover new disease areas with the help of advanced technologies and accelerate its way to the polypeptide market. The use of advanced technologies in pharmaceutical as well as skincare applications of polypeptides can help manufacturers to consolidate a stronger position in the polypeptides market.
Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=796
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Get More Industry Insights At: https://www.linkedin.com/company/factmr
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polypeptide Market Prediction Report 2018: Chemotherapeutic Medicines and Anti-Cancer Pharmaceuticals will Drive the Global Market here
News-ID: 1068770 • Views: …
More Releases from Fact.MR
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083
The demand for dry powder inhalers is expected to rise due to the…
Global ISO Certification Market is projected to expand at a CAGR of 15.2% from 2 …
According to a recently released Fact.MR analysis, the global market for ISO certification is expected to be valued at US$ 16.14 billion by 2024. By the end of 2034, revenue from ISO certification is expected to grow at a 15.2% compound annual growth rate and reach a market valuation of US$ 66.25 billion.
In order to prove compliance with environmental, quality, or information security rules, a variety of sectors require ISO…
Gluten-free Bakery Products Market is expected to grow at a CAGR of 9.8% from 20 …
The gluten-free bakery products market is a dynamic sector influenced by various factors such as consumer dietary preferences, health trends, and advancements in food technology. As awareness of celiac disease and gluten sensitivities grows, so does the demand for gluten-free alternatives in baked goods.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3035
Gluten is a protein fraction generated from wheat, rye, barley, oats, and their derivatives and hybrids. It is an essential part…
Pet Grooming Services Market is projected to expand at a CAGR of 7.2% from 2024 …
The global pet grooming services market is anticipated to rise at a compound annual growth rate (CAGR) of 7.2%, from a value of US$ 3.3 billion in 2024 to US$ 6.7 billion by the end of 2034, according to the most recent market research analysis published by Fact.MR.
Pets are now considered members of the family by many. Pet owners want the best for their furry pals, just as much as…
More Releases for Polypeptide
Islet Amyloid Polypeptide: Therapeutic Developments to Witness Growth
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Islet amyloid polypeptide (IAPP) or Amylin is a peptide hormone. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. It inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. The molecules developed by companies in Phase II, Phase I and Preclinical stages…
Polypeptide Market Discern Magnified Growth By 2028
With an increasing number of patients diagnosed with cancer, many pharmaceutical companies are conducting intensive research to discover effective anti-cancer drugs. The World Health Organization (WHO), cancer was the second leading cause of death, killing over 8.8 million people across the globe. 70% patients in low- or middle-income countries, who are diagnosed with cancer succumb to death. It generates needs for an effective oncology medicine that can reduce the number…
Polypeptide Market Analysis , Trends, Opportunity, 2018 to 2028
Global Polypeptides Market: Overview
Polypeptides, the organic polymers containing a large number of amino-acids bonded together on the form of a chain, represent essential portions of proteins with unique pharmacokinetic properties as compared to small molecule drugs and large proteins. Polypeptides play a crucial role in modulating cellular functions and coordinating intercellular communications. There are hardly any other classes of bio-molecules that offer as much chemical diversity as polypeptides do.
Researchers have…
Global Collagen Polypeptide Market Analysis with Forecast to 2025
The Global Collagen Polypeptide Market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025
Scope of the report:
The Global Collagen Polypeptide Market report by Research Cosmos provides a comprehensive analysis of the market including the current trends, growth factors and future forecast. The report also offers deep insights into…
Gastric Inhibitory Polypeptide Receptor-Pipeline Review H2 2017
The report 'Gastric Inhibitory Polypeptide Receptor-Pipeline Review, H2 2017' outlays comprehensive information on the Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
According to the recently published report 'Gastric Inhibitory Polypeptide Receptor-Pipeline Review, H2 2017'; Gastric Inhibitory Polypeptide Receptor…
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polype …
ReportsWorldwide has announced the addition of a new report title Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
According to the recently published report 'Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H2 2017'; Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 14 molecules. Out of which…
